The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? Review uri icon

Overview

abstract

  • The recent finding of overexpression of the polycomb group transcriptional repressor EZH2 in prostate cancer raises the possibility that transcriptional regulation at the chromatin level may play a role in the development of the metastatic phenotype and suggests new avenues of exploration with respect to patient stratification and therapeutics.

publication date

  • November 1, 2002

Research

keywords

  • Biomarkers, Tumor
  • Prostatic Neoplasms
  • Proteins
  • Repressor Proteins

Identity

Scopus Document Identifier

  • 0038002683

Digital Object Identifier (DOI)

  • 10.1016/s1535-6108(02)00187-3

PubMed ID

  • 12450788

Additional Document Info

volume

  • 2

issue

  • 5